Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 05-2012 | 03-2012 | 02-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,332 | -4 | -3,572 | N/A | -3,260 |
| Depreciation Amortization | 38 | N/A | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 89 | 1 | -111 | N/A | 340 |
| Other Working Capital | 83 | 1 | -189 | N/A | 500 |
| Other Operating Activity | 6,505 | 3 | 2,649 | 0 | 1,640 |
| Operating Cash Flow | $-1,618 | $0 | $-1,223 | $N/A | $-780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | -3 | N/A | -3 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -10 |
| Purchase Sale Intangibles | -1,083 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,277 | 0 | -198 | 0 | 3 |
| Investing Cash Flow | $-1,280 | $N/A | $-201 | $N/A | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 839 | N/A | 839 | N/A | N/A |
| Common Stock Issued | 2,045 | N/A | 541 | N/A | 763 |
| Other Financing Activity | 35 | 0 | 35 | 0 | 37 |
| Financing Cash Flow | $2,919 | $N/A | $1,415 | $N/A | $800 |
| Beginning Cash Position | 10 | 4 | 10 | N/A | 0 |
| End Cash Position | 31 | 4 | 1 | N/A | 10 |
| Net Cash Flow | $21 | $0 | $-9 | $N/A | $10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,618 | 0 | -1,223 | N/A | -780 |
| Capital Expenditure | -4 | N/A | -3 | N/A | -3 |
| Free Cash Flow | -1,621 | 0 | -1,225 | 0 | -783 |